In the autosomal dominant disorder epidermolytic hyperkeratosis, the structural integrity of the keratin intermediate filaments is altered in the suprabasallayers of the epidermis. We and others have used genetic linkage studies and mutation analysis to establish that single amino acid substitutions in either the keratin 1 or keratin 10 chains can cause epidermoly tic hyperkeratosis. However, a larger database of mutations is required to better understand the relationship between specific mutations in these keratin chains and their effect on keratin filament structure. A larger database will also provide a catalog that may be useful for genetic counseling purposes. In this paper, we report the identification of three new mutations of the keratin 1 chain of epidermolytic hyperkeratosis pro bands in highly conserved residues in the T he quantitatively major differentiation products of epidermal cells are the cytoskeletal keratin intermediate filaments (KIF) . Normal human epidermis expresses two major type I/type II pairs of KIF chains: type II keratin 5 (K5) and type I K14 in the proliferative-potential basal cells, and type II Kl (and K2) and type I KlO in the suprabasal terminally differentiating epidermal cells. Together, these chains form the cytoplasmic KIF complement of these cells that in large measure is responsible for the physical properties of the entire epidermis [1, 2] .
In the autosomal dominant disorder epidermolytic hyperkeratosis, the structural integrity of the keratin intermediate filaments is altered in the suprabasallayers of the epidermis. We and others have used genetic linkage studies and mutation analysis to establish that single amino acid substitutions in either the keratin 1 or keratin 10 chains can cause epidermoly tic hyperkeratosis. However, a larger database of mutations is required to better understand the relationship between specific mutations in these keratin chains and their effect on keratin filament structure. A larger database will also provide a catalog that may be useful for genetic counseling purposes. In this paper, we report the identification of three new mutations of the keratin 1 chain of epidermolytic hyperkeratosis pro bands in highly conserved residues in the T he quantitatively major differentiation products of epidermal cells are the cytoskeletal keratin intermediate filaments (KIF) . Normal human epidermis expresses two major type I/type II pairs of KIF chains: type II keratin 5 (K5) and type I K14 in the proliferative-potential basal cells, and type II Kl (and K2) and type I KlO in the suprabasal terminally differentiating epidermal cells. Together, these chains form the cytoplasmic KIF complement of these cells that in large measure is responsible for the physical properties of the entire epidermis [1, 2] .
Recent exciting molecular genetic and molecular biology experiments have demonstrated that mutations in the KIF chains expressed in the epidermis are etiologically responsible for at least three distinct types of autosomal dominant genetic skin diseases, epidermolysis bullosa simplex (EllS), epidermolytic hyperkeratosis (EH), and palmar-plantar hyperkeratosis (reviewed in l3 -7] ).
In EH, the integrity of the suprabasal layers of the epidermis is seriously disrupted, resu lting in an altered differentiation program and highly abnormal, thickened stratum corneum [8,9J . Several types of data have now led to the understanding that the major underlying cause of this genetic disorder is mutation in either the Kl or KI0 chain. Cells of affected EH epidermis contain abnormal clumps of the KIF in the cytoplasm often found around the nucleus and near the cell periphery at desmosomal junctions [8 -1 0] . Using Manuscript received August 20, 1993 ; accepted for publication October 4, 1993. Reprint requests to: Dr. Peter M. Steinert, National Institutes of Health, Building 6, Room 425, Bethesda, Maryland 20892.
Abbreviations: EBS, epidermolysis bullosa simplex; EH, epidermolytic hyperkeratosis; KIF, keratin intermediate fi laments; PASA, polymerase chain reaction amplification of specific alleles.
H1 or beginning of the lA rod domain segments. These correspond to regions involved in molecular overlaps between neighboring molecules in keratin filaments . Using an in llitro assay, synthetic peptides bearing these substitutions show diminished capacity to disassemble preformed filaments in lIitro in comparison to the wild type peptides. Moreover, analyses of all mutations in epidennolytic hyperkeratosis known to date demonstrate remarkable clustering in the molecular overlap region. We conclude that non-conservative substitutions in the overlap region are likely to interfere with normal keratin filament structure and function, leading to pathology. Key words: genodermatoses/ intennediate fila men ts/ epidermolysis bullosa simplex/epidermis. ] Inllest Dermatol 102: [17] [18] [19] [20] [21] [22] [23] 1994 this as an important clue to the disease etiology, our laboratory tested keratins, among other candidate genes, for linkage to EH in one large family, and found complete co-segregation of the disorder with the type II keratin gene locus on chromosome 12q [11 J. Because Kl is the major type II keratin expressed in suprabasal epidermis, we reasoned that a defect in this gene may underlie the pathology. Indeed, sequence analyses of DNA obtained from all affected members of the family revealed a single point mutation in residue position 17 of the HI region of the keratin 1 gene that changed a CTT (leucine) to a CCT (proline), but not in any unaffected members of the family [12] . Simultaneously, two other research groups reached the conclusion that defects in the Kl or KIO gene could cause EH. One of these employed transgenic technology using a chimeric gene construct bearing the likely promoter region of the KI0 gene and part of the KI0 coding sequences coupled to a deletion form of the K14 coding sequences, to direct expression of the dominant-negative phenotype to the suprabasal layers of the epidermis. Newborn transgenic mice displayed an abnormal epidermal phe . notype and changes in the supra basal layers reminiscent of the clinical features of EH in humans [13] ; thus it was concluded that KI0 is a likely candidate for the disease etiology. Subsequent sequence analyses of DNA from affected patients of two occurrences of EH revealed the same arginine to histidine mutation at residue position 10 (RI0H) of the lA rod domain segment in the KI0 protein [14] . A concurrent study by another group reported point mutations in either the Kl or 100 chain in three EH patients [15] : arginine to histidine at position 10 (R 1 OH) of the 1 A rod domain segment of KI0, leucine to serine at position 15 (U5S) of the lA rod domain segment of KI0, and glutamic acid to glutamine at position 118 (E118Q) of the 2ll rod domain segment of Kl. More recently, a mutation involving a leucine to proline substitution at position 6 (S6P) of the lA rod domain segment of Kl was found to 0022-202X/94/S06.00 Copyright © 1994 by The Society for Investigative Dermatology, Inc.
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cause EH in another family [16] . Finally, linkage analyses in three other families have been reported in which the disease gene was mapped to the 12q region that contains the type II genes [17] , thereby again implicating the K1 gene in disease etiology.
Thus five different mutations that cause EH have been identified to date in either the Kl or KID chains. There are a number of important reasons it is necessary to generate a larger body of data on mutations that cause disease. First, for clinical diagnosis, it would be useful to determine whether there is a correlation between disease presentation and the type or location of mutation in either keratin chain. If indeed there are "hotspots" for mutations in the keratin chains as suggested [5, 6] , this would in turn facilitate identification of further mutations in the future simply because investigators will know where to look. Second, the creation of such a "catalog" of mutations will be of benefit for the future development of rational therapeutic approaches for the disease. Similarly, the availability of this information will be useful in genetic counseling of patients whose planned children are at risk of inheriting the disease-causing mutation. Additionally, an important spinoff may be a better understanding of KIF structure and function, which in turn may aid in diagnosis and treatment.
To establish a catalog, we are in the process of analyzing the DNA from a large number of families with EH . In this paper, we report three new mutations in the K 1 chain resulting in amino acid substitutions in different probands, and provide evidence that such substitutions are likely to severely affect KIF structure and function ill I/i/ro, and by extrapolation, ill villo as well.
MATERIALS AND METHODS
Source of DNA DNA was isolated as described (1 8) from freshly drawn blood or transformed lymphocyte cel l lines obtained from both affected and unaffcctcd family mcmbers, as well as from additional unaffected unrelated persons.
Direct PCR Atnpli6.cation of Keratin 1 Gene Exons Oligonucleotide primcrs for amplification ofK1 exollS in fivc fragments, and primers for direct sequencing of these fragments are given below, based on the published human K1 gene sequence [12, 19) . Some primers were as used in a previous stud y [1 2) and co ntained 5' sequences encod ing a restriction enzyme site (lowercase letcers) in addition co Kl specific sequences (uppercase letters); plus sign means sense strand and minus sign means antisensc strand. Amplifications were done on a DNA Thermal Cyclcr (Perkin-Elmer) for 35 cycles (1, denaturation for 60 seconds at 94 ·C; 2, a 90-second transition to I 55·C; 3, annea ling for 30 seco nds at 5S·C; 4, transition for 30 scconds to 72 ·C; and 5, extension for 90 seconds at 72·C). Amplifications were preceded by a hot start: 5 -10 min incubation of the DNA and primer mix at 95-100·C, and equilibration to 80-85 · C, at which time th e premixed dNTPs, PCR buffer, MgCl z ' and Taq polymerase werc added and cycling started. To increasc the yield ofpCR product for direct sequencing, reamplifi cation was pcrformcd on a 1 : 100 to 1 : 1000 dil ution of the first amplification rcaction. The primers uscd in the first PCR reactions were as follows: fragmcnt I, primcr 1 (+)/4n(-) or GII(+)/4n(-); fragment II, primcr 5(+)/ 6(-); fragment III, primer 6(+)/10(-}; fragment IV, primer 4411(+)/ 2470(-); and fragment V, primcr 13(+)/15(-) . The primers used in reamplification rcactions were as follows: fragment I, primer GII(+}/4n(-); fragment II, primcr 5(+)/6(-); fragment Ill, primer 6{+)/10(-); fragmenr IV, primcr 108(+)/2470(-); and fragment V, primer 13(+)/15(-). The amplified DNA fragments were resolved on 1.5% agarose gels and purified by the GeneClean II procedure (Bio 101) or by the Magic PCR Preps DNA purification system (Promega).
DNA Fragmellt I (Ineluding Exotl
Sequencing Procedures Direct scquencing of th e PCR-amplified DNA was done in reactions using the sin gle-strand binding protein (US Biochcmica ls) to prevent strand reassociation [20) . A 1 : 8 dilution of the labe ling mix and about 300-500 ng of gel-purified DNA fragment were used for each direct sequencing reaction with the Sequenase 11 kit (US Biochemicals). Standard 6% denaturing polyacrylamidc gels wcre run. The primers used in direct sequencing reactions were as follows: exon 1, primer J(+)/4n(-); exon 2, primer 5(+)/6n(-); exon 3, primer 6(+}; exon 4, primer E4sp(+}; exon 5, primer E5sp(+); exon 6, primer 10{-); cxon 7, primer 108{+)/ 12(-); and exons 8 and 9, primer 13(+)/15(-). These primers permitted analysis of most of the sequence ofKl , except for the variable Vl and V2 end domain regions.
Screening Assays for Kl Mutations We developed assays that did not require DNA sequcncin g to facilitate the dctection of each identified mutation in patients and to screen for the occurrence of that mutation in the normal population. The V11 G substitution of family 1027 rcsults in the loss of a Mae III restriction enzyme site in DNA amplified from ex on 1 using primcrs GII(+) and 4n(-). Completed peR reactions (50 ,ul) were adjusted as recommended by Boehringer-Mannheim Biochemicals with NaCl, MgCl z , and Tris-HCl and digested with 2 units of Mae III for 2-4 h, and analyzed on 3% agarose gels (NuSieve 3: 1, FMC Corp.). The N8S substitution in family 1002 results in the creation of a new Ode I site. The altered Ode I cleavage pattern was examined as above, exccpt that 2 units of enzyme were added directly to the completed PCR reaction. For the S13P substitution in family 3138, a PCR amplification of specific alleles (PAS A} assay was developcd [21 ) . In this assay, PCR amplification is obtained specifically from the wildtype or th e mutant allele usi ng primers that differ only at the 3' most nucleotidc (sec primers listed above). The primers SPwt(-), specifi c for the wildtypc base T, and SPmut(-) specifi c for the mutation C, were each used with GII(+) as the second primer. Amplifications were performed with 0.1 mM dNTP, 1.5 mM MgCl z ' 120 ng DNA, and O.l,uM primers in 25,ul for 30 cycles of 60-second denacuration at 95 ·C, 60-second annealing at 55 · C, and 60-scco nd extension at 72 · C.
Linkage Analysis Linkage analysis in family 1027 was performed using the computer program LINKAG E, subprogram MLINK on a 386 personal compu ter [12) . EH was modeled as a fully penetrant disorder with allele frequency of 0.001. Analysis was robust over a range of disease and marker allele frequencies as all individuals incl uded in the analysis were genotyped.
Synthetic Peptides The following peptides, based on published sequences of human K10 [22) and mouse and human K1 [231 chains, were synthesized and purified by high-press ure liquid chromatography, and their compositions confirmed and concentrations ascertai ned by amino acid ana lysis: 1} wildtype Kl Hl, 1 -36, PVCSPGGIQEVTINQSLLQPLNVEID-PEIQKVKSRE; 2) mutant K1 H1, VllG, PVCSPGGIQEQTINQS-LLQPLNVEIDPEIQKVKSRE; 3) wildtype Kl lA, REQIKSLNNQ-FASFIDKVRFMEQQNKVLQTKWELL; 4) wildtype K1 lA, 1-18, REQIKSLNNQFASFIDKV; 5) wildtype Kl lA. 18 -35, VRFLEQQN-KVLQTKWELL; 6} mutant K1 lA. N8S, REQIKSL~NQFASFIDKV; 7) mutant K11A, S13P, REQIKSLNNQFA!:FIDKV.
KIF Disassembly Assay
In Vitro Human KIF con tai ning the Kl/K5/ KI0/K14 chains were prepared from frcshly excised foreski n epidermis as described previously [24) , and cquilibrated into a buffer of 5 mM Tris-HCl (pH 7.6) containing 1 mM eth ylenediaminetetraacetic acid and 1 mM dithiothreitol. Peptides were disso lved in the buffer at 3 mg/ ml immediately before use, and added in 3 ILl aliquots to 0.25 ml of KIF so as to effect a twofo ld molar excess of peptide over KIF heterodimer (110 kDa) . At molar ratios exceedin g about 2: 1, peptides 1-3 began to aggregate the KIF instead, apparentl y due to an ionic zipper effect [25] . C hanges in tu rbidity were monitored by measuring .light scatterin g at 310 nm in a Beckman DU-65 spectroph otometer at 37"C for 60 min [12, 24, 25] . We have determined empiricall y by electron mIcroscopy [11 ,25] that for KIF 2-5 ILm 111 length, turbidity due to lI ght scatter111g IS approxImately proportIonal to the square of KIF length; that is, minor changes in KIF length wi ll result in significa ntly reduced turbid ity.
RESULTS
During the course of the analysis of several EH families, we have discovered three hitherto undescribed mutations in the K1 gene that are the likel y cause of the disease.
Clinical Description of Patients The diagnosis ofEH was confirmed by histopathology from skin biopsy specimens obtained from at least one affected person of each family. Patients in family I027 had primarily palmar and plantar involve ment and truncal sparing . There was thick hyperkeratosis of the palms and soles, with a relatively smooth surface and sharp bo rder delineated by a red halo. In some patients, there was restriction of full extension of the palms and di~its. Blistering from trauma ?r irritati~n (such as restrictive cloth1l1g) was reported, altho ug h It was a mIld component of the disease and tended to decrease with age. C hildren had som e generalized involvement, particularly of the fl ex ures and scaling at the corner of the lips, all of which improved over time. Patients IDD2 and 3138 had severe palmar-plantar hyperkeratosis with contractures of the pa.lms and digits . One pat~e nt had surgical amputations of rwo di gits secondary to I11fectlOn. Both patIents were erythrodermic and had generalized hyperkeratosis, most severe over the joints, both fl exor and extensor surfaces. Inter-articul ar areas and most of the trunk were covered with fine white scale. The analysis and confirmation of these mutations are set forth below by family .
The 1027 Family This is a three-ge neration family with six affected individuals (Fig la) . Linkage analyses with the polymorphic markers developed in the V2 glycine loop sequences ofKl and KID described previously [11,26 ,27] documented an obligatory recombination berween the disease phenotype and the K1D locus at 17q (denoted by asterisk in Fig 1a) . This excluded the possibility that a defect in K10 accounted for the disease in this family. The KRTI (K1) gene, however, was fully informative and showed complete cosegregation with a m ax imum lod score of 2. 1 at e = O. Direct sequencing of all exons of the K1 gene (except the V1 and V2 regions of exom 1 and 9, respectively) in an affected individual amplified by PCR revealed hetero geneity at a single base position in exon 1 GGC in one Kl allele and GTC in the other allele. This leads to a substitution of va li ne for glycine in residue position 11 of the HI domain (VII G) (Fig 1 b) . DNA amplified from exon 1 of an unaffected individual did not show the same change. We then devised a tes t for the prese nce of this po int mutation throug hout the pedigree and in the normal control population. The T to G substitution destroys a restriction enzyme recognition site for M ae III (GTNAC) in the disease allele. The PCR product of exon 1 is 497 bp long, which for normal all.eles is cleaved by M ae III into fragments of 297, 107, and 93 bp (Fig 1 c) . However, the loss of the site due to the mutation gives a composite fragment of 390 bp (297 + 93) from the disease allele, as well as the fragm en ts expected from the normal allele. Thus individuals heterozygous for this mutation w ill display four bands upo n Mae III digestion (Fi g Id) . U sing the appearance of the composite 390-bp band as the assay, we documented that all affected members of this family possessed the mutant allele, but only the normal allele was prese nt in the eight unaf- A valine to glycine mutation in family 1027. A) Pedigree of three ge neration fa mil y. Below each perso n is indicated the genotype with respect to the po lymorphic markers used for either the Ki0 (KRT10) or K1 (KRT1) loc i. For example, person 1-1 has size all eles 1 and 3 at the KRT I0 locus, and the 1 and 2 size alleles at th e KRTl locus. These polymorph isms are due to variable numbers of glycine loops in the V2 subdomain regions of the K1 and KI0 ge nes [26, 27] . By following the co-segregation of alleles through th e family, it ca n be seen th at in person 11-4 (asterisk), there is an obligate recombination betwee n the disease locus and the KRT1 0 locus: she inherited the KRTI0-3 allele from her affected fath er, whereas her affected sibs inherited the KRTlO-I allele and her unaffected sib inherited the KRTlO-3 allele. On the other hand, th ere is complete cosegregation with the KRT 1 (Kl) locus, with all affected individuals inheriting the KRTI-2 allele fro m 1-1, whereas none of the alfecteds did. Individuals III-2 and III-6 were not tested (ND) as they were under 1 year of age, although they clea rly had the EH phenotype. B) Portion of a sequencing gel of an affected (left set oJlnt/es) and unaffected (right set oj Inl/es) fam ily member, which shows an additional band in the G position, representin g a nucleotide substitution in one allele resulting in a va line to glycine change. C) This mutation causes the loss of a Mae III restriction el12yme site in affected persons. I n the PCR product used for this work, affected persons possess a novel composite 390 bp band, which is used here to demonstrate th at all unaffected persons of the fami ly and unrelated unaffected persons do not carry this substitution. Markers are 123-bp ladder (Gibco-BRL). [~\
fee ted family members and in 53 unrelated unaffected individuals (a tota l of 106 alleles).
The 1002 Family This family consisted of a single affected individual and her two normal parents (Fig 2a) . We amplified exons 1, 2, 5, and 7 of the Kl gene, which encode virtually the entire rod domain including the Hl, lA, L12, and 2B segments. By direct sequencing, we found a single nucleotide substitution in one allele in residue position 8 of the lA rod domain segment (AAC to AGC, asparagine to serine) (N8S) in the affected child II-I (Fig 2b) . DNA from both unaffected parents did not show this mutation (only parent 1-1 is shown) . This nucleotide substitution creates a Dde I restriction enzyme si te (CTNAG), which was then used as a tes t for the presence of the mutation in PCR-amplified DNA. In this analysis, the normal alleles yield Dde I fragments of 347 and 150 bp, but the affected allele yields fragments of347, 103 (Fig 2c) , and 47 bp.
Because neither of the unaffected pare nts displays the new Dde I fragme nts, the A to G substitution in the affected child represents a new mutation. Similarl y, 50 other normal unrelated individuals also lacked th e fragments of 103 and 47 bp.
The 3138 Family This family also consisted of a single affected child and two normal parents (Fig 3a) . Direct sequence analyses of D NA amplified from exons 1,2,5 , and 7 from the affected individua11l-1 identified a si ngle nucleotide substitution in one allele ofKl at position 13 of the 1 A rod domain segment (TCC to CCC, serine to proline) (S13P) (Fig 3b) . N either of the parents showed this change. T his was confirmed as a new mutation as both Kl alleles fro m the parents showed only the T at this position (only parent 1-1 is shown). T he nucleotide substitution removes an Mnl I restriction enzyme recognition site, but because there are several Mnl I sites in the peR product of exon 1 util ized in this work, the pattern was too complex for use. Therefore, a PASA assay was used to selectively amplify the w ildtype all ele or th e allele cartying the mutation (see 
Materials and Methods).
Only the affected individual gave a PCR product with both the mutant and wildtype-specific primers, whereas both unaffected parents were negative w ith the primer bearing th e mutation (Fig 3c) . T he PCR product for the mutant allele was not detected in 47 unrel ated unaffected individuals using the mutated primer.
Additional Nucleotide Sequence Variations in the Kl Gene During the course of sequencing nllIn erous normal Kl all eles in this study, we found three hitherto undescribed single nucl eotide sequence variations. None of these segregate with EH suggesting they represent functionally equivalent alleles in the normal human popul ation. Two silent codon variants were in the 2B rod domain segm ent, one at lysine 66 (codons AAA or AAG, estimated allele frequencies of 0. 95 and 0.05 , respectively), and the other at arginine 91 (CGT or CGC, estimated allele frequencies of 0.5 each) . The third nucleotide variation is in the second position of codon 11 of the E2 end domain segment (AAG lysine or AGG arginine, estimated allele frequ ency of 0.75 and 0.25, respectively).
Use of Synthetic Peptides in Functional Assays for Kl Mutations W e have previously demonstrated that synthetic pep tides corresponding in amino acid sequence to three principal overlap re gions ofK1/KlO KIF ca n be used to disassemble preformed KIF ill vitro [24, 25] , presumabl y due to competition with the similar sequence on the chains in th e intact KIF. These regions are the Hl end domain, lA, and end of 2B rod domain sequences. Peptides from other portions of the keratin chains or unrelated proteins do not promote disassembly [24,2 5] .
Interestingly, the three new mutations described here for Kl lie within these sequences, and so synthetic peptides bearing the resulting substitutions were tested using turbidity to monitor the degree of KIF structural change (Table I ). The fu ll-length wildtype H1 peptide promoted massive disassembly of preformed human Kl/ 1 (right set of larres) . The gel of the unaffected mother 1-2 was the same as 1-1. The patient shows an add itional band in the C position in one allele resu lting in the substitution of a proline for se rine res idue. C) A PASA assay using primers specific for either the normal Kl gene sequen ce (a 3' T), or the mutant sequence (a 3' C), were used to test for the presence of the Illutation. DNA from the affected child II-I yields an amp lified band of 433 bp with both the mutant (M) and wildtype (WT) primers. However, only the wild type primers amplify the DNA from the unaffected parents, 1-1 and 1-2. Markers are Hae III digestion of<l>X 174 DNA (Gibco-BRL).
Kl0 to subfilamentous particles containing only one to four molecules w ithin 90 min [1 2,25] . However, the peptide bearing the Vl1 G amino acid substitution seen in fami ly 1027 was much less effective; electron microscopy revealed (data not shown) that the slight decrease in turbidity (Table I , lill e 2) was due to reductions in KIF length from > 2 to 0.5 -1 fJ.m. Even after 6 h , the KIF were sti ll largely intact. The fu ll-length wildtype lA peptide also promoted KERATIN [25] . This property is retained within the sequence of the first 18 residues rather than the second 18 (Table I , compare line 4 with lilies 3 and 5) as peptide 5 containing residues 18 -35 of the Kl chain had on ly a minor effect on KIF length. Notably, peptides bearing the N8S substitution of family 1002 or the S 13P substitution offamily 3138 (Table1, lines 6, 7) only shortened KIF, and did not promote massive disassembly, even after 6 h.
These data show that the three substituted peptides do not function like the wildtype peptides presumably because their structures have been altered. Because of their altered structures they are unable to effectively compete with the native sequences in the KIF in the same way as the wildtype peptides. By extension, we infer th at the ful l-length mutant K1 chains are unable to function normally in the KIF ill IJivo because of altered structure, promoting the pathology ofEH.
DISCUSSION
This laboratory has initiated a major project to identify the likely disease-causing mutation in a coll ection ofEH cases for the purpose of building a "cata log" with two major purposes in mind . First, if it turns out that the mutations are clustered in specific sequence regions of the keratin chains, such data would make further characterization of mutations for this disease far easier and systematic because workers will then know where to focus attention in the future. Thus prospects for genetic counseling and prenatal diagnosis are likely to be enhanced. Second, the occurrence of the mutations in the keratin chains may provide important clues to the structure of KIF and their dynamic functions in cells. An important spinoff of such models may be improved therapeutic interventions, management, or even cure of the disease.
Mutations in Keratins Causing EH Are Clustered In this paper, we report three new mutations for EH that occur in the K1 chain. These occur only in affected patients and not in unaffected family members. We have described strategies for the analysis and sequencing of amplified DNA of patients, and tests to ensure that they are the likely causative mutation, not merely rare sequence polymorphisms within the normal human population. Each of the amino ac id substitutions occurs in highly conserved sequence regions of the H1 and lA domains encoded by exon 1 of the K1 gene.
In addition we have reported one other mutation position in the 77 ± 0
• The data are expressed as the percent oflight scattering remaining after 60 min and are the average ± SO of two or three measurements on one batch of human K 1 / K 1 0 KIF. We have used electron microscopy to assess these chan ges [12, 24] . For example, 0% means the KIF have becn totally disassembled to subfilamentous particles and no longer scatter light. whereas 77% means the KIF arc still largely intact with minor shortcning and/or unravcling. Wildeype peptides were designed from the published K 1 sequellce [1 9,23). The thrce mutant pep tides were designed bascd on the identified substitutions see n in th e K 1 chain in the three families studied here. with existing published data [12] [13] [14] [15] ' this means there are now 10 known different amino acid positions that are changed in the Kl or KI0 chains in EH, from a total of 18 separate families reported (Table II) . Compilation of these data (Table II) reveals a non-random distribution of mutations: two (11 %) occur in HI, 14 (78%) (six positions) occur in the first half of the 1A rod domain sequences, and two (11 %) occur in sequences at the end of the 2B rod domain. Accordingly, we can speculate that most mutations in EH patients will be discovered following the amplification of only the first exon of the keratin chains, as described here for K1. Because 14 of 18 mutations occur in the first 15 residues of the lA rod domain, this region may constitute a "hot window" of increased mutational sensitivity in EH. Furthermore, mutations in the RIO position of K 10 represent nearly half of all the cases ofEH described so far. That is, this may represent a "hot spot" for mutations in EH [4] [5] [6] . Interestingly, this same position has been described as a hot spot for mutations in the K14 gene in EBS [4] [5] [6] 29] . However, we and others may have ascertained a biased set of EH patients who were likely referred to research protocols and whose disease presentation may not be representative of the full spectrum of EH patients. Nevertheless, the present insights should aid greatly the future identification of mutations in the keratin genes causing these genodermatoses.
Most Mutations Occur in Critical Overlap Regions of the Keratin Chains Recent studies have suggested advanced twodimensional models for K1/K10 KIF structure [25] that are of relevance for mutations in EH. Cross-linking analyses showed there are three principal modes by which a pair of antiparallel molecules may be aligned in the KIF, and have provided estimates of the axial dimensions of these modes: All' in which the two molecu les are staggered by about 16 nm so that their 1B rod domain segments are overlapped; A 22 , in which the two molecules are staggered by about 28 nm so that their segments 2B are overlapped; and A 12 , in which the two molecules are aligned in register (staggered by about 1 nm) . Several cross-links established that the axial repeat length (45 nm) of molecules in a KIF is demonstrably less than the length of each molecule (46 nm). Thus these data permitted identification of a fourth mode of alignment, termed A CN , in which about the last 1 nm of the 2B rod domain segment of one molecule overlaps with the first 1 nm of the lA rod domain segment of a similarly directed molecule. This corresponds to a nominal overlap of about 10 amino acids of the lA and 2B sequences. This means that the sequence regions H1, beginning of lA, end of 2B and H2 all lie very close to and/or overlap each other within a KIF. Furthermore, we [24] have suggested that the H1 (and possibly H2) subdomaills, immediately adjacent to the beginning and end of the rod domain, are involved in the alignment of nearest neighbor molecules in KIF, perhaps by THE JOURNAL OF INVESTIGATIVE DERMATOLOGY ionic interactions of basic residues in H 1 with the canonical acidic residues of the end of the 2B rod domain segment. In the All and A22 alignment modes, these sequence regions also overlap with the middle of the rod domain, near the L2 segment. These structural principles may explain why these five regions represent the most highly conserved sequences throughout the family of keratin and other IF chains [30 -32] .
Interestingly, all 12 substitutions known so far for EH occur in or near these conserved overlap sequence regions. Of the 12 substitutions, six lie within the nominal 10 residue 1A-2B ACN overlap window; three others lie just outside the window; and two occur in H1. No mutations have been observed yet in H2 or L2 sequences.
However, little is yet known about how the molecules fold in three dimensions to form the intact KIF. It appears that inappropriate amino acid substitutions in either of the HI, lA, or 2B sequences that participate in the ACN overlap are the most critical for KIF structure and function. Presumably key ionic, van der Waals and/or H -bonds are prevented (or introduced) that markedly affect molecular packing, stability, and thus KIF dynamics in the living epithelial cells [5 ,6] . Apparently, mutations lying in residue positions just outside of the overlap window interfere with KIF structure as much as those within the window, so that amino acids that should align or interact in three dimensions are unable to do so. Further structural studies are in progress to address these questions .
Other Mutations in EH This laboratory has been unable to find mutations in the rod domain sequences of the K1 or K10 chains in seven of 19 (37%) probands of EH. Further work will be necessary to determine whether such mutations reside in the V1 or highly variable V2 end domain sequences, other keratin genes expressed in the epidermis such as K2e and K9, or even in other genes coexpressed in terminally differentiating epidermis.
Is There a Correlation Between Disease Presentation and Mutation in EH? We note that the clinical presentations of the family members of four cases reported here and previously [12] involving the K1 chain all display severe palmar-plantar (palm and sole) hyperkeratosis. In contrast, truncal involvement is pronounced whereas seVere palmar-plantar hyperkeratosis is absent in those families with KlO mutations (JJ. DiGiovanna and S.]. Bale, submitted). This observation raises the intriguing question as to whether it may be possible in the future to predict the nature and location of the causative mutation based UPO? the clinical presentation of the disease. Analyses of many addItIonal cases of EH may establish whether this association is valid.
